<SEC-DOCUMENT>0001171843-11-003603.txt : 20120110
<SEC-HEADER>0001171843-11-003603.hdr.sgml : 20120110
<ACCEPTANCE-DATETIME>20111128124233
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0001171843-11-003603
CONFORMED SUBMISSION TYPE:	CORRESP
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20111128

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Capstone Therapeutics Corp.
		CENTRAL INDEX KEY:			0000887151
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				860585310
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		CORRESP

	BUSINESS ADDRESS:	
		STREET 1:		1275 WEST WASHINGTON STREET
		STREET 2:		SUITE 101
		CITY:			TEMPE
		STATE:			AZ
		ZIP:			85281
		BUSINESS PHONE:		6022865520

	MAIL ADDRESS:	
		STREET 1:		1275 WEST WASHINGTON STREET
		STREET 2:		SUITE 101
		CITY:			TEMPE
		STATE:			AZ
		ZIP:			85281

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ORTHOLOGIC CORP
		DATE OF NAME CHANGE:	19940211
</SEC-HEADER>
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.htm
<TEXT>
<html>
<head>
    <title>corresp_112811.htm</title>
    <!--Licensed to: NASDAQ-->
    <!--Document Created using EDGARizerAgent 5.4.1.0-->
    <!--Copyright 1995 - 2009 Thomson Reuters. All rights reserved.-->
</head>
<body bgcolor="#ffffff">
<div style="TEXT-INDENT: 0pt; DISPLAY: block"><img src="logo.jpg" alt=""><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">November 28, 2011</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Jeffrey Riedler</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Assistant Director</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">United States Securities and Exchange Commission</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">100 First Street, N.E.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Washington, DC 20549</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-FAMILY: ; ">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Re:&#160;</font></div>
</td>
<td align="left">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Capstone Therapeutics Corp. (the &#8220;Company&#8221;)</font></div>

<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Item 1. Business</font></div>

<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font size="2"> </font>
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 27pt; MARGIN-RIGHT: 0pt"><font size="2"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Patents, Licenses and Proprietary Rights, page 6</font></font></div>

<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font size="2"> </font>
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font size="2"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Form 10-K</font></font></div>

<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font size="2"> </font>
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font size="2"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Filed on March 29, 2011</font></font></div>

<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font size="2"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">File No. 001-33560</font></font></div>
</div>
</div>
</div>
</div>
</td>
</tr></table>
</div>

<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Your letter dated November 18, 2011.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Mr. Riedler:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Following is our response to your letter dated November 18, 2011. We have included your specific comment prior to our response to facilitate your review.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Item 1. Business</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Patents, Licenses and Proprietary Rights, page 6.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">1. We note your response to our prior comment, however we believe that royalty rates and termination provisions are material terms of your license agreements and material to an investor&#8217;s understanding of your business. Based on Section 16 of your agreement with AzTE it appears that either party may terminate the agreement under the circumstances described therein. Accordingly, please provide proposed disclosure that expands your discussion of your agreements with AzTE and the University of Texas to include the royalty rates payable on sales of future products and, for your agreement with AzTE, to include the termination provisions of the agreement.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Our Response:</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We continue to believe the response included in our letter to you dated October 29, 2011 is correct and that the terms you describe are not material to the understanding of our business and not required disclosure under Regulation S-K, Item 101(h)(4)(vii).</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font color="gray" style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">1275 West Washington Street, Suite 101 &#9679; Tempe, AZ&#160;&#160;85281 &#9679; Office 602-286-5520 &#9679; www.capstonethx.com</font></div>
</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="4">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font color="gray" style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">SEC Correspondence</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font color="gray" style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">November 28, 2011</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font color="gray" style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Page 2 of 3</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">However, while we disagree with the SEC&#8217;s interpretation of its regulations, we also believe the requested disclosure will not be materially misleading and we therefore agree to include the following expanded disclosure under Patents, Licenses and Proprietary Rights in our next annual report on Form 10-K (as it may be further modified to reflect new developments or other changes in our business):</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Patents, Licenses and Proprietary Rights</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">As part of our purchase of CBI on August 5, 2004, the license agreements between CBI and OrthoLogic for the development, use, and marketing of the therapeutic products utilizing Chrysalin were replaced by a direct license agreement between OrthoLogic and the University of Texas.&#160;&#160; Subsequently, we entered into an agreement whereby the University of Texas assigned to us certain patents previously exclusively licensed to us.&#160;&#160;Under this agreement, we must pay the University of Texas royalties of 3.3% of covered product sales, and 5% of covered sublicense fees and we must pay various other fees in connection with filing and maintaining Chrysalin-related patents. This obligation will expire upon the expiration of the subject patents. Chrysalin has been patented in the United States and in some other countries for a number of methods of use, including cardiovascular indications.&#160;&#160;A composition of matter patent covering European countries expired in 2007 and the corresponding United States patent expired in 2011.&#160;&#160;Our other patents for Chrysalin expire between 2021 and 2024.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">As part of the February 27, 2006 AzERx transaction, we acquired a license from AzTE, an affiliate of Arizona State University, for worldwide rights to AZX100 for all indications.&#160;&#160;Under the license agreement with AzTE, we are required to pay patent filing, maintenance and other related patent fees as well as royalties of 3% of covered product sales and 5% of covered license revenue.&#160;&#160;These obligations will end on the expiration of the last patent.&#160;&#160;The license is supported by patents that expire from 2022 to 2024.&#160;&#160;The license agreement is subject to termination by AzTE for events such as non-compliance with material terms of the license agreement, bankruptcy or liquidation, Force Majeure and non-payment of amounts due.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">As part of the February 27, 2006 AzERx transaction we also acquired a non-exclusive license from Washington University for transduction domain carrier patents which form part of AZX100.&#160;&#160;Under the license, we are required to pay license maintenance payments and royalties of 2% of covered product sales.&#160;The license is supported by patents that expire in 2018.&#160;These obligations will end on the expiration of the last patent.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">We are a development stage research and development company with no products currently approved by the FDA for marketing.&#160;&#160;We do not expect to have products approved for marketing before 2016, if ever.&#160;&#160;Accordingly, the foregoing royalty obligations currently do not affect our reported results.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Capstone Therapeutics is a registered United States domestic trademark of Capstone Therapeutics Corp.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font color="gray" style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">1275 West Washington Street, Suite 101 &#9679; Tempe, AZ&#160;&#160;85281 &#9679; Office 602-286-5520 &#9679; www.capstonethx.com</font></div>
</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="4">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div>
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font color="gray" style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">SEC Correspondence</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font color="gray" style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">November 28, 2011</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font color="gray" style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Page 3 of 3</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company acknowledges that:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt" face="Symbol, serif">&#183;&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company is responsible for the adequacy and accuracy of the disclosure in the filing;</font></div>
</td>
</tr></table>
</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt" face="Symbol, serif">&#183;&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Staff comments or changes to disclosure in response to staff comments do not foreclose the Commission from taking any action with respect to the filing; and</font></div>
</td>
</tr></table>
</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt" face="Symbol, serif">&#183;&#160;&#160;</font></div>
</td>
<td>
<div style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company may not assert staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Please contact me if we can be of further assistance.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Sincerely,</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">/s/&#160;&#160;&#160;Les M. Taeger</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Les M. Taeger</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Senior Vice President and Chief Financial Officer</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Capstone Therapeutics Corp</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
<div style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font color="gray" style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">1275 West Washington Street, Suite 101 &#9679; Tempe, AZ&#160;&#160;85281 &#9679; Office 602-286-5520 &#9679; www.capstonethx.com</font></div>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>logo.jpg
<TEXT>
begin 644 logo.jpg
M_]C_X``02D9)1@`!`@$`8`!@``#_X1`017AI9@``34T`*@````@`!P$2``,`
M```!``$```$:``4````!````8@$;``4````!````:@$H``,````!``(```$Q
M``(````;````<@$R``(````4````C8=I``0````!````I````-````!@````
M`0```&`````!061O8F4@4&AO=&]S:&]P($-3(%=I;F1O=W,`,C`Q,3HQ,#HR
M-B`Q-3HQ,SHR,0```````Z`!``,````!__\``*`"``0````!````NJ`#``0`
M```!````10`````````&`0,``P````$`!@```1H`!0````$```$>`1L`!0``
M``$```$F`2@``P````$``@```@$`!`````$```$N`@(`!`````$```[:````
M`````$@````!````2`````'_V/_@`!!*1DE&``$"`0!(`$@``/_M``Q!9&]B
M95]#30`"_^X`#D%D;V)E`&2``````?_;`(0`#`@("`D(#`D)#!$+"@L1%0\,
M#`\5&!,3%1,3&!$,#`P,#`P1#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,
M#`$-"PL-#@T0#@X0%`X.#A04#@X.#A01#`P,#`P1$0P,#`P,#!$,#`P,#`P,
M#`P,#`P,#`P,#`P,#`P,#`P,#`P,_\``$0@`.P"@`P$B``(1`0,1`?_=``0`
M"O_$`3\```$%`0$!`0$!``````````,``0($!08'"`D*"P$``04!`0$!`0$`
M`````````0`"`P0%!@<("0H+$``!!`$#`@0"!0<&"`4###,!``(1`P0A$C$%
M05%A$R)Q@3(&%)&AL4(C)!52P6(S-'*"T4,')9)3\.'Q8W,U%J*R@R9$DU1D
M1<*C=#87TE7B9?*SA,/3=>/S1B>4I(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F
M]C='5V=WAY>GM\?7Y_<1``("`0($!`,$!08'!P8%-0$``A$#(3$2!$%187$B
M$P4R@9$4H;%"(\%2T?`S)&+A<H*20U,58W,T\24&%J*R@P<F-<+21)-4HQ=D
M154V=&7B\K.$P]-UX_-&E*2%M)7$U.3TI;7%U>7U5F9VAI:FML;6YO8G-T=7
M9W>'EZ>WQ__:``P#`0`"$0,1`#\`]322224I))))2DDDI"2E))G/:UI<XAK0
M)).@6;9UEMSS5TVI^;8#!>W2II_E7GV_YB9/)&.Y^SU2_P`1(B2Z1('/`Y6=
M=UF@6FC#:[-R1S75JT3I[[?H-7+=9^M.(S(^PV6OZUU(F&]'Z:)K!_.;DY(:
M_P"C_A-OZ6K_`$:I7=*ZUU!GI_67)'3\(P6?5[IA#7.'_FPRI=^XQS]]E^__
M``7H/3)&8B92(PX_WIGUR_ZG^BN$1="YR[#Y7H\3ZTVV6VP*,^FH_IA@6MML
MH_DWU`_I/^.9^C6SA=3P>H5EV)<VP@>YG#Q_6K/N7GF5T7H;K&#'H/1[L9H&
M+G]/+VVU:.;^F:YWZ\WW?I;-]&7_`,*IWY76.G`977L4=5P!K7]8>E0V]@&[
MW9M#=C?9[-_J,J]+_376*/%D]SB]C)[E'7%F'!E_P>#]%?.%5QQX/ZT?5'_$
M?3)27*]'Z_E9&/\`:>GY%?7\%D;G5>S*KG_3T/VN_-_.;[UMX'6NGYYVTV[;
MFZ/HLEEC3^ZZM\*6.>/%PR!QY/W)^G_G?)+_``6,P-6*D.X;Z26X3'=)2K5)
M)))*4DDDDI__T/4TI\EG]>ZWA]"Z5?U/,/Z*D#:QOTGO=[:J:_Y=C_\`THLW
M!Z)G=3K;F?62ZXWW-#F],HN?3CX[3[FU/^S/J?F9#?\`#W9%EK/4_F:_32K2
MU/13^*4KE/K#]7^JX'3;\OZK9^5C9%;9=AOL=DU6,&MK:69WVE^-D;/YK[.[
M\ST?3]_J5]-DY%6+CW9-SMM..QUMCO!K!O<?P1(4DGR0LC[3L/V4,]0][-T#
M^RSZ:Y3ZK974,/ZR=3Z/U-[WOSZJ^KXK+#.SU?T>=C-<7?0Q[ME--?\`HZEO
M?62BNWH/4`\$;<>VQI:2UP>QK[:[&/K+7-<UXW(2C9KNH'JQ/1WW`V=2N.8\
M:LHUKH!'`V-G_.L6%F_5CZT];L^S=6ZE3TWI!EIP>E!P<]I+ALNR;V,_,=[O
M9Z%G_<9$^K/0\;J?U2Z=D/MOHSKL</\`MM5UK;18[_#;O4_2?\7;^B6=A_6W
MJ?4OJYT9EUWV3-ZGG_LS*SJF@>UI=ZMN-S75E9>VNJM_I>FRU]UE5=?Z-"&,
M0),!K?JE+67VI,B=_L>BQ/JU3TC%^Q_5^JGI]3A^ENASKWG^7<[W_G?GN_XK
MTD`?5G,Y]:N3).CB23^<YWTE:R?JW0746X-^1AWX]U=A>,BY[;6,>'649C+;
M'_:67LW;M_Z7_A$V/]5,$/R;,F[*MLR<BV\M;E9%3&"UYL;573CW55-VM+=_
MM]]BCR<OBR&YF4OK^Q=#+*&D:#1M^J>>YY>V^KRT<(@*>']7>LX%WJXF756X
M_2:0[:^/S;&?]^_G?^$5#ZK=/JZCF==KS;\RYF#U&S'Q6G-R@&5-#=M;=N0W
M_I+;IQ<#ZLX_4^H6WVG#,9+_`%K'W/9Z=;:G5LMR'V76[MC/28^S^<L47^C^
M7C(R`D)>$B%QYC(11HAS.I_4'!S+6]1Z?8>A];`DY6`2*W.//JT#T]S+/S_Y
MK?\`X7UE9PNB]:R&>G]9QAY;JV@59^)OJR"?^%9L97[O^"?Z?_`*71\7.ZYA
MU=5ZS9;37EM]7%Z;CV.JKKI?[Z?M#Z#7D9>4ZO\`27>J_P!#_1X]:M7_`%=8
MQA?TG)OZ=DMUK<VQ]E1/89&)D/LIMK_TFWT[O^&5J48RCP3J?3U>K?\`K,0)
M!L:,L;"ZQAOV59;<O%X#<D$6-'@V^KZ7_7%JC29^?DL;ZN]8'7,"^O+K;3G8
MEC\/J6,TDM;:SV/-3OI_9[OYREW]CU/T:Y_&S\CZH]:R*<BU]OU6R,D4576O
M=8["O-=-FVRZW<]N%>ZW8W>_]'_VY]H;CQ"-@$Z?HD\0_P`'B3*5T2]SN3SY
M%1<QMC'5O&YKP6N'B'?27-4=)PS]4<RD>H-IR[&6^J\VM?6^^NFUE[G.MWU,
MK8VM/`NO-#T_R27"_4'HG3^K_53!ZAU(79.9;ZPLN=D7R=MUM;/HW-;[6-:N
MEZ5T&CI.;D68=EOV7)K8/L]MMEH8]A>2ZG[0^QU?JMM_2>[_``:1`M3_`/_1
MVOKT]V7]:OJKTAQ_5W91RKF'4.-19Z>X?U&W,_ZZNY`'^OBN%_QC568.?T'Z
MS`$X_2\H,S-HDBJUS/?Q]'V6U?U[:EW#'-<`YAW,<):X&00=01_)1/RQ[*ZL
MED?6,W6U8W3<:MEUN;<W?58]U;#101DY/J6,KO\`T=NRO%?^C_[4K7*Q&OR_
M^<%N7E5.&'52<;$<QEMC]Q?ZF78]C*=C&7[*&U>G;_@?^VT%%POK8_JN#U#I
M/UIRL6C'JZ5>*LNRF]UQ./E'[/=ZC7XV+_,[OT?N_P`,NHZ]KT'J4:C[)?K_
M`-;L57ZP-KZIT3-Z;7399;ETOI8+*;F-#W`^E8Y_HOVMJM_2*C3^VA]4W=)R
MJ1;U,8IPVV,%_HOEAH;D66OQM[-M?Z2WV?SJ.]'L5(/JIB=6ROJ=TNFKJ#<2
MBS'8"ZFC]8##RVK(MOMI99_POV3^PM3(^I_0;_J^WZO.Q]G3ZQ^BVG])6^7.
M&35:[=^L;WO]_P#+V6?HOT:']5FW]*Z%B=-SZW-OQ&"HNIKNLK>UI.RQKG45
MN][?S'J75+.I/S\+-Z586C';:S(Q;Z,@,N;8:BR;*Z7NH?3Z-CJ[O3L_\%>D
M;L^:G%/4?K+]3KJ6]9O_`&S]7K'MI'42(RL8O(;7]LY]>K]^SW_\9_-8UO;-
MF3\=%S75J\SKN/7T_J&-]EZ<^RNS,:QM]UEHJ>V]F-7MQJ?1KLMK9ZESG>IL
M]C*O\(MQW4*8)#+R>P%%W_5>DA+6NBGG?J1_RA]:/_3M;^1J-_C)QK\GZD]3
MKH!<YK66N`_<KMKNM_S:ZW/0OJOC=2Z9F]6MZA2&U=3RW9E9H%]CF%_M]"UI
MQJMWL_PM?Z-="<W&<TM<RYS7"'`X]QD<:_H43\UJZ+=*NHR>F8>1CF:;J*GU
MG^26-<Q6RN9P,?*Z(XX_2-V1TMSG.KP<FJ^M]&XE[F8N6RB[=1[O9C9%7Z/_
M`$ZL969UW+9Z%31TQC]+,@5W9-S0?^X]?V>G';9^[;;;;Z?^@0KKW5;F?4MC
MK/K-];<VO7%LRZZ&.[&VAMGVD?V?5K6U5AXF>WK&%F5"[&R,DLMJ=PX&C%T_
M>W?G,>WZ"ETMG3.E8->#ATWLHJ!B:+W.<22ZRRQ[J=[[;'^][T'I63F4W]0?
MG4&NO)R#=C&IEUAV>G50UE[/0;LN_0^I[/9^D_X-$ZDE3E=!S<CZM=3K^J?5
MKG68=W_(.?;^>P&/V;?9]'[31]&C_2?S;/3_`%:I:N/_`.)C,^&=/_;N2GZ]
MA]+Z[TU^!EUWACB'U6MHN%E5K9]+(I/I;FV5N_Z'L0>G4Y>-]3[<7.>ZW+HQ
MKQ?<YKV^HYWJO]:;F5/>ZQKM]GY^_P#G/>B-2#U,@IPO\77UAZ3@_4W`Q\FU
M[;6>L7-;3<\";K7:.II>QWM*ZGH/U@PNNUY5^"7.IQL@XP>YKF%Q8RJVQWIV
MAEE>U]_I^_\`<61_BNG_`)B].'G?_P"?[ET]5%-5EUE;`UV0\67$?G/#*Z=[
MO^M4U,3959\U!__2],R\3'S<:W$RJA=CWL-=M3OHN:>=W_F/T%@8'1OK-T(-
MP^EY&/U+I-8/V>C/?93?2/S*&9F/5DMR*&?F>M1^C_FO\&NF21%UX*<9N%U_
M.M)ZK=3B8;7!S</`<]S[(+7M^T]0M9C6>EO;[J<;&Q_4_P`+D>CZE3]*BJUE
MU[WN)8]P-0+B8&T;_:?H?I-Z.DFFK%J'5I9F/FV6[J+2QFQHVAT218U[_P"K
M^B]B/ELNLQ;:Z'%EKFD5N$B#V.Y&230(^JCYIUT8U![:VA^K@/<>56P*,REK
MVY-A?N,M.XN+?Y'"MI)4/3J?#Q5KJUKJ\MV3396Z*F2+&3HX/'N=_7J<UGI_
MVT^93?=4UE+S6[>TO<"0=L_I-I_>V_05A)(U4M>JM=&`8X4>F'.<X-VASOI$
MQ])Q_>4,-E]>-6R]Q?:UH#W$S+H$N1DD=.+Z*Z-.BC+9D[['[JAZNFXF=[V/
MH]D?X*L.8BY%5MEE#F.+6LL)M`<6RW;8W;[?I?I75O1TDT"-&B?F"3:',KNL
MQGLH);88VNG;$$?G)\IEUF/8RA_IVN:0Q\<'LBI)VFODA'2'-8`06DF2TDNC
MX.*SNHX_5W=/S<?#;7=;DA[*/M%CF-K%C2PNL>RNUSV5N]S*VM_ZXM5)(5Z:
M/DKN\G]5NE?6SZO=$HZ.[%P,P8YL++VY=M6CWNNA[#@7>_?8_P!ZU^GU]?LZ
MB_)ZFW'QL1E0KQL7&M?=[W&;;K[+:,7\UC&4;&?GVK523S=H?__9_^T4ME!H
M;W1O<VAO<"`S+C``.$))300E```````0`````````````````````#A"24T#
M[0``````$`!@`````0`!`&`````!``$X0DE-!"8```````X`````````````
M/X```#A"24T$#0``````!````!XX0DE-!!D```````0````>.$))30/S````
M```)```````````!`#A"24T$"@```````0``.$))32<0```````*``$`````
M`````CA"24T#]0``````2``O9F8``0!L9F8`!@```````0`O9F8``0"AF9H`
M!@```````0`R`````0!:````!@```````0`U`````0`M````!@```````3A"
M24T#^```````<```_____________________________P/H`````/______
M______________________\#Z`````#_____________________________
M`^@`````_____________________________P/H```X0DE-!`@``````!``
M```!```"0````D``````.$))300>```````$`````#A"24T$&@`````#10``
M``8``````````````$4```"Z````"`!I`&T`80!G`&4`,``P`#(````!````
M``````````````````````$``````````````+H```!%````````````````
M``````$`````````````````````````$`````$```````!N=6QL`````@``
M``9B;W5N9'-/8FIC`````0```````%)C=#$````$`````%1O<"!L;VYG````
M``````!,969T;&]N9P``````````0G1O;6QO;F<```!%`````%)G:'1L;VYG
M````N@````9S;&EC97-6;$QS`````4]B:F,````!```````%<VQI8V4````2
M````!W-L:6-E241L;VYG``````````=G<F]U<$E$;&]N9P`````````&;W)I
M9VEN96YU;0````Q%4VQI8V5/<FEG:6X````-875T;T=E;F5R871E9`````!4
M>7!E96YU;0````I%4VQI8V54>7!E`````$EM9R`````&8F]U;F1S3V)J8P``
M``$```````!28W0Q````!`````!4;W`@;&]N9P``````````3&5F=&QO;F<`
M`````````$)T;VUL;VYG````10````!29VAT;&]N9P```+H````#=7)L5$58
M5`````$```````!N=6QL5$585`````$```````!-<V=E5$585`````$`````
M``9A;'1486=415A4`````0``````#F-E;&Q497AT27-(5$U,8F]O;`$````(
M8V5L;%1E>'1415A4`````0``````"6AO<GI!;&EG;F5N=6T````/15-L:6-E
M2&]R>D%L:6=N````!V1E9F%U;'0````)=F5R=$%L:6=N96YU;0````]%4VQI
M8V5697)T06QI9VX````'9&5F875L=`````MB9T-O;&]R5'EP965N=6T````1
M15-L:6-E0D=#;VQO<E1Y<&4`````3F]N90````ET;W!/=71S971L;VYG````
M``````IL969T3W5T<V5T;&]N9P`````````,8F]T=&]M3W5T<V5T;&]N9P``
M```````+<FEG:'1/=71S971L;VYG```````X0DE-!"@```````P````!/_``
M```````X0DE-!!$```````$!`#A"24T$%```````!`````$X0DE-!`P`````
M#O8````!````H````#L```'@``!NH```#MH`&``!_]C_X``02D9)1@`!`@$`
M2`!(``#_[0`,061O8F5?0TT``O_N``Y!9&]B90!D@`````'_VP"$``P("`@)
M"`P)"0P1"PH+$14/#`P/%1@3$Q43$Q@1#`P,#`P,$0P,#`P,#`P,#`P,#`P,
M#`P,#`P,#`P,#`P,#`P!#0L+#0X-$`X.$!0.#@X4%`X.#@X4$0P,#`P,$1$,
M#`P,#`P1#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#/_``!$(`#L`H`,!
M(@`"$0$#$0'_W0`$``K_Q`$_```!!0$!`0$!`0`````````#``$"!`4&!P@)
M"@L!``$%`0$!`0$!``````````$``@,$!08'"`D*"Q```00!`P($`@4'!@@%
M`PPS`0`"$0,$(1(Q!4%181,B<8$R!A21H;%"(R054L%B,S1R@M%#!R624_#A
M\6-S-1:BLH,F1)-49$7"HW0V%])5XF7RLX3#TW7C\T8GE*2%M)7$U.3TI;7%
MU>7U5F9VAI:FML;6YO8W1U=G=X>7I[?'U^?W$0`"`@$"!`0#!`4&!P<&!34!
M``(1`R$Q$@1!46%Q(A,%,H&1%*&Q0B/!4M'P,R1BX7*"DD-3%6-S-/$E!A:B
MLH,')C7"TD235*,79$55-G1EXO*SA,/3=>/S1I2DA;25Q-3D]*6UQ=7E]59F
M=H:6IK;&UN;V)S='5V=WAY>GM\?_V@`,`P$``A$#$0`_`/4TDDDE*22224I)
M)*0DI229SVM:7.(:T"23H%FV=9;<\U=-J?FV`P7MTJ:?Y5Y]O^8F3R1CN?L]
M4O\`$2(DND2!SP.5G7=9H%IHPVNS<D<UU:M$Z>^WZ#5RW6?K3B,R/L-EK^M=
M2)AO1^FB:P?SFY.2&O\`H_X3;^EJ_P!&J5W2NM=09Z?UER1T_",%GU>Z80US
MA_YL,J7?N,<_?9?O_P`%Z#TR1F(F4B,./]Z9]<O^I_HKA$70N<NP^5Z/$^M-
MMEML"C/IJ/Z88%K;;*/Y-]0/Z3_CF?HULX74\'J%9=B7-L('N9P\?UJS[EYY
ME=%Z&ZQ@QZ#T>[&:!BY_3R]MM6CF_IFN=^O-]WZ6S?1E_P#"J=^5UCIP&5U[
M%'5<`:U_6'I4-O8!N]V;0W8WV>S?ZC*O2_TUUBCQ9/<XO8R>Y1UQ9AP9?\'@
M_17SA5<<>#^M'U1_Q'TR4ERO1^OY61C_`&GI^17U_!9&YU7LRJY_T]#]KOS?
MSF^];>!UKI^>=M-NVYNCZ+)98T_NNK?"ECGCQ<,@<>3]R?I_YWR2_P`%C,#5
MBI#N&^DEN$QW24JU22222E))))*?_]#U-*?)9_7NMX?0NE7]3S#^BI`VL;])
M[W>VJFO^78__`-*+-P>B9W4ZVYGUDNN-]S0YO3*+GTX^.T^YM3_LSZGYF0W_
M``]V19:SU/YFOTTJTM3T4_BE*Y3ZP_5_JN!TV_+^JV?E8V16V78;['9-5C!K
M:VEF=]I?C9&S^:^SN_,]'T_?ZE?39.15BX]V3<[;3CL=;8[P:P;W'\$2%))\
MD+(^T[#]E#/4/>S=`_LL^FN4^JV5U##^LG4^C]3>][\^JOJ^*RPSL]7]'G8S
M7%WT,>[9337_`*.I;WUDHKMZ#U`/!&W'ML:6DM<'L:^VNQCZRUS7->-R$HV:
M[J!ZL3T=]P-G4KCF/&K*-:Z`1P-C9_SK%A9OU8^M/6[/LW5NI4]-Z09:<'I0
M<'/:2X;+LF]C/S'>[V>A9_W&1/JST/&ZG]4NG9#[;Z,Z['#_`+;5=:VT6._P
MV[U/TG_%V_HEG8?UMZGU+ZN=&9==]DS>IY_[,RLZIH'M:7>K;C<UU967MKJK
M?Z7ILM?=9577^C0AC$"3`:WZI2UE]J3(G?['HL3ZM4](Q?L?U?JIZ?4X?I;H
M<Z]Y_EW.]_YWY[O^*])`'U9S.?6KDR3HXDD_G.=])6LGZMT%U%N#?D8=^/=7
M87C(N>VUC'AUE&8RVQ_VEE[-V[?^E_X1-C_53!#\FS)NRK;,G(MO+6Y614Q@
MM>;&U5TX]U53=K2W?[??8H\G+XLAN9E+Z_L70RRAI&@T;?JGGN>7MOJ\M'"(
M"GA_5WK.!=ZN)EU5N/TFD.VOC\VQG_?OYW_A%0^JW3ZNHYG7:\V_,N9@]1LQ
M\5IS<H!E30W;6W;D-_Z2VZ<7`^K./U/J%M]IPS&2_P!:Q]SV>G6VIU;+<A]E
MUN[8STF/L_G+%%_H_EXR,@)"7A(A<>8R$4:(<SJ?U!P<RUO4>GV'H?6P).5@
M$BMSCSZM`]/<RS\_^:W_`.%]96<+HO6LAGI_6<8>6ZMH%6?B;ZL@G_A6;&5^
M[_@G^G_P"ET?%SNN8=75>LV6TUY;?5Q>FX]CJJZZ7^^G[0^@UY&7E.K_`$EW
MJO\`0_T>/6K5_P!76,87])R;^G9+=:W-L?943V&1B9#[*;:_])M].[_AE:E&
M,H\$ZGT]7JW_`*S$"0;&C+&PNL8;]E66W+Q>`W)!%C1X-OJ^E_UQ:HTF?GY+
M&^KO6!US`OKRZVTYV)8_#ZEC-)+6VL]CS4[Z?V>[^<I=_8]3]&N?QL_(^J/6
MLBG(M?;]5LC)%%5UKW6.PKS739MLNMW/;A7NMV-WO_1_]N?:&X\0C8!.GZ)/
M$/\`!XDRE=$O<[D\^147,;8QU;QN:\%KAXAWTES5'2<,_5',I'J#:<NQEOJO
M-K7UOOKIM9>YSK=]3*V-K3P+KS0]/\DEPOU!Z)T_J_U4P>H=2%V3F6^L++G9
M%\G;=;6SZ-S6^UC6KI>E=!HZ3FY%F'9;]ER:V#[/;;9:&/87DNI^T/L=7ZK;
M?TGN_P`&D0+4_P#_T=KZ]/=E_6KZJ](<?U=V4<JYAU#C46>GN']1MS/^NKN0
M!_KXKA?\8U5F#G]!^LP!./TO*#,S:)(JM<SW\?1]EM7]>VI=PQS7`.8=S'"6
MN!D$'4$?R43\L>RNK)9'UC-UM6-TW&K9=;FW-WU6/=6PT4$9.3ZEC*[_`-';
MLKQ7_H_^U*URL1K\O_G!;EY53AAU4G&Q',9;8_<7^IEV/8RG8QE^RAM7IV_X
M'_MM!1<+ZV/ZK@]0Z3]:<K%HQZNE7BK+LIO=<3CY1^SW>HU^-B_S.[]'[O\`
M#+J.O:]!ZE&H^R7Z_P#6[%5^L#:^J=$S>FUTV66Y=+Z6"RFYC0]P/I6.?Z+]
MK:K?TBHT_MH?5-W2<JD6]3&*<-MC!?Z+Y8:&Y%EK\;>S;7^DM]G\ZCO1[%2#
MZJ8G5LKZG=+IJZ@W$HLQV`NIH_6`P\MJR+;[:66?\+]D_L+4R/J?T&_ZOM^K
MSL?9T^L?HMI_25OESADU6NW?K&][_?\`R]EGZ+]&A_59M_2NA8G3<^MS;\1@
MJ+J:[K*WM:3LL:YU%;O>W\QZEU2SJ3\_"S>E6%HQVVLR,6^C(#+FV&HLFRNE
M[J'T^C8ZN[T[/_!7I&[/FIQ3U'ZR_4ZZEO6;_P!L_5ZQ[:1U$B,K&+R&U_;.
M?7J_?L]__&?S6-;VS9D_'1<UU:O,Z[CU]/ZAC?9>G/LKLS&L;?=9:*GMO9C5
M[<:GT:[+:V>I<YWJ;/8RK_"+<=U"F"0R\GL!1=_U7I(2UKHIYWZD?\H?6C_T
M[6_D:C?XR<:_)^I/4ZZ`7.:UEK@/W*[:[K?\VNMST+ZKXW4NF9O5K>H4AM74
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MIU.7C?4^W%SGNMRZ,:\7W.:]OJ.=ZK_6FYE3WNL:[?9^?O\`YSWHC4@]3(*<
M+_%U]8>DX/U-P,?)M>VUGK%S6TW/`FZUVCJ:7L=[2NIZ#]8,+KM>5?@ESJ<;
M(.,'N:YA<6,JML=Z=H997M??Z?O_`'%D?XKI_P"8O3AYW_\`G^Y=/51359=9
M6P-=D/%EQ'YSPRNG>[_K5-3$V56?-0?_TO3,O$Q\W&MQ,JH78][#7;4[Z+FG
MG=_YC]!8&!T;ZS="#</I>1C]2Z36#]GHSWV4WTC\RAF9CU9+<BAGYGK4?H_Y
MK_!KIDD1=>"G&;A=?SK2>JW4XF&UP<W#P'/<^R"U[?M/4+68UGI;V^ZG&QL?
MU/\`"Y'H^I4_2HJM9=>][B6/<#4"XF!M&_VGZ'Z3>CI)IJQ:AU:69CYMENZB
MTL9L:-H=$D6->_\`J_HO8CY;+K,6VNAQ9:YI%;A(@]CN1DDT"/JH^:==&-0>
MVMH?JX#W'E5L"C,I:]N387[C+3N+BW^1PK:25#TZGP\5:ZM:ZO+=DTV5NBID
MBQDZ.#Q[G?UZG-9Z?]M/F4WW5-92\UNWM+W`D';/Z3:?WMOT%822-5+7JK71
M@&.%'IASG.#=H<[Z1,?2<?WE##9?7C5LO<7VM:`]Q,RZ!+D9)'3B^BNC3HHR
MV9.^Q^ZH>KIN)G>]CZ/9'^"K#F(N15;990YCBUK+";0'%LMVV-V^WZ7Z5U;T
M=)-`C1HGY@DVAS*[K,9[*"6V&-KIVQ!'YR?*9=9CV,H?Z=KFD,?'![(J2=IK
MY(1TAS6`$%I)DM)+H^#BL[J./U=W3\W'PVUW6Y(>RC[18YC:Q8TL+K'LKM<]
ME;O<RMK?^N+522%>FCY*[O)_5;I7UL^KW1*.CNQ<#,&.;"R]N7;5H][KH>PX
M%WOWV/\`>M?I]?7[.HOR>IMQ\;$94*\;%QK7W>]QFVZ^RVC%_-8QE&QGY]JU
M4D\W:'__V3A"24T$(0``````4P````$!````#P!!`&0`;P!B`&4`(`!0`&@`
M;P!T`&\`<P!H`&\`<````!(`00!D`&\`8@!E`"``4`!H`&\`=`!O`',`:`!O
M`'``(`!#`%,````!`#A"24T$!@``````!P`&`````0$`_^$8`FAT='`Z+R]N
M<RYA9&]B92YC;VTO>&%P+S$N,"\`/#]X<&%C:V5T(&)E9VEN/2?ON[\G(&ED
M/2=7-4TP37!#96AI2'IR95-Z3E1C>FMC.60G/SX*/'@Z>&UP;65T82!X;6QN
M<SIX/2=A9&]B93IN<SIM971A+R<@>#IX;7!T:STG6$U0('1O;VQK:70@,RXP
M+3(X+"!F<F%M97=O<FL@,2XV)SX*/')D9CI21$8@>&UL;G,Z<F1F/2=H='1P
M.B\O=W=W+G<S+F]R9R\Q.3DY+S`R+S(R+7)D9BUS>6YT87@M;G,C)R!X;6QN
M<SII6#TG:'1T<#HO+VYS+F%D;V)E+F-O;2]I6"\Q+C`O)SX*"B`\<F1F.D1E
M<V-R:7!T:6]N(')D9CIA8F]U=#TG=75I9#IA-&(X83DW."TP,#%F+3$Q93$M
M8C=C8BUE,#0S,S$T8F8R8S$G"B`@>&UL;G,Z97AI9CTG:'1T<#HO+VYS+F%D
M;V)E+F-O;2]E>&EF+S$N,"\G/@H@(#QE>&EF.D-O;&]R4W!A8V4^-#(Y-#DV
M-S(Y-3PO97AI9CI#;VQO<E-P86-E/@H@(#QE>&EF.E!I>&5L6$1I;65N<VEO
M;CXQ.#8\+V5X:68Z4&EX96Q81&EM96YS:6]N/@H@(#QE>&EF.E!I>&5L641I
M;65N<VEO;CXV.3PO97AI9CI0:7AE;%E$:6UE;G-I;VX^"B`\+W)D9CI$97-C
M<FEP=&EO;CX*"B`\<F1F.D1E<V-R:7!T:6]N(')D9CIA8F]U=#TG=75I9#IA
M-&(X83DW."TP,#%F+3$Q93$M8C=C8BUE,#0S,S$T8F8R8S$G"B`@>&UL;G,Z
M<&1F/2=H='1P.B\O;G,N861O8F4N8V]M+W!D9B\Q+C,O)SX*(#PO<F1F.D1E
M<V-R:7!T:6]N/@H*(#QR9&8Z1&5S8W)I<'1I;VX@<F1F.F%B;W5T/2=U=6ED
M.F$T8CAA.3<X+3`P,68M,3%E,2UB-V-B+64P-#,S,31B9C)C,2<*("!X;6QN
M<SIP:&]T;W-H;W`])VAT='`Z+R]N<RYA9&]B92YC;VTO<&AO=&]S:&]P+S$N
M,"\G/@H@(#QP:&]T;W-H;W`Z2&ES=&]R>3X\+W!H;W1O<VAO<#I(:7-T;W)Y
M/@H@/"]R9&8Z1&5S8W)I<'1I;VX^"@H@/')D9CI$97-C<FEP=&EO;B!R9&8Z
M86)O=70])W5U:60Z831B.&$Y-S@M,#`Q9BTQ,64Q+6(W8V(M93`T,S,Q-&)F
M,F,Q)PH@('AM;&YS.G1I9F8])VAT='`Z+R]N<RYA9&]B92YC;VTO=&EF9B\Q
M+C`O)SX*("`\=&EF9CI/<FEE;G1A=&EO;CXQ/"]T:69F.D]R:65N=&%T:6]N
M/@H@(#QT:69F.EA297-O;'5T:6]N/CDV+S$\+W1I9F8Z6%)E<V]L=71I;VX^
M"B`@/'1I9F8Z65)E<V]L=71I;VX^.38O,3PO=&EF9CI94F5S;VQU=&EO;CX*
M("`\=&EF9CI297-O;'5T:6]N56YI=#XR/"]T:69F.E)E<V]L=71I;VY5;FET
M/@H@/"]R9&8Z1&5S8W)I<'1I;VX^"@H@/')D9CI$97-C<FEP=&EO;B!R9&8Z
M86)O=70])W5U:60Z831B.&$Y-S@M,#`Q9BTQ,64Q+6(W8V(M93`T,S,Q-&)F
M,F,Q)PH@('AM;&YS.GAA<#TG:'1T<#HO+VYS+F%D;V)E+F-O;2]X87`O,2XP
M+R<^"B`@/'AA<#I#<F5A=&5$871E/C(P,3$M,3`M,C94,34Z,3,Z,C$M,#@Z
M,#`\+WAA<#I#<F5A=&5$871E/@H@(#QX87`Z36]D:69Y1&%T93XR,#$Q+3$P
M+3(V5#$U.C$S.C(Q+3`X.C`P/"]X87`Z36]D:69Y1&%T93X*("`\>&%P.DUE
M=&%D871A1&%T93XR,#$Q+3$P+3(V5#$U.C$S.C(Q+3`X.C`P/"]X87`Z365T
M861A=&%$871E/@H@(#QX87`Z0W)E871O<E1O;VP^061O8F4@4&AO=&]S:&]P
M($-3(%=I;F1O=W,\+WAA<#I#<F5A=&]R5&]O;#X*(#PO<F1F.D1E<V-R:7!T
M:6]N/@H*(#QR9&8Z1&5S8W)I<'1I;VX@<F1F.F%B;W5T/2=U=6ED.F$T8CAA
M.3<X+3`P,68M,3%E,2UB-V-B+64P-#,S,31B9C)C,2<*("!X;6QN<SIX87!-
M33TG:'1T<#HO+VYS+F%D;V)E+F-O;2]X87`O,2XP+VUM+R<^"B`@/'AA<$U-
M.D1O8W5M96YT240^861O8F4Z9&]C:60Z<&AO=&]S:&]P.F$T8CAA.3<W+3`P
M,68M,3%E,2UB-V-B+64P-#,S,31B9C)C,3PO>&%P34TZ1&]C=6UE;G1)1#X*
M(#PO<F1F.D1E<V-R:7!T:6]N/@H*(#QR9&8Z1&5S8W)I<'1I;VX@<F1F.F%B
M;W5T/2=U=6ED.F$T8CAA.3<X+3`P,68M,3%E,2UB-V-B+64P-#,S,31B9C)C
M,2<*("!X;6QN<SID8STG:'1T<#HO+W!U<FPN;W)G+V1C+V5L96UE;G1S+S$N
M,2\G/@H@(#QD8SIF;W)M870^:6UA9V4O:G!E9SPO9&,Z9F]R;6%T/@H@/"]R
M9&8Z1&5S8W)I<'1I;VX^"@H\+W)D9CI21$8^"CPO>#IX;7!M971A/@H@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*/#]X
M<&%C:V5T(&5N9#TG=R<_/O_N``Y!9&]B90!D0`````'_VP"$``("`@("`@("
M`@(#`@("`P0#`@(#!`4$!`0$!`4&!04%!04%!@8'!P@'!P8)"0H*"0D,#`P,
M#`P,#`P,#`P,#`P!`P,#!00%"08&"0T*"0H-#PX.#@X/#PP,#`P,#P\,#`P,
M#`P/#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#/_``!$(`$4`N@,!$0`"
M$0$#$0'_W0`$`!C_Q`&B````!P$!`0$!```````````$!0,"!@$`!P@)"@L!
M``("`P$!`0$!``````````$``@,$!08'"`D*"Q```@$#`P($`@8'`P0"!@)S
M`0(#$00`!2$2,4%1!A-A(G&!%#*1H0<5L4(CP5+1X3,68O`D<H+Q)4,T4Y*B
MLF-SPC5$)Y.CLS875&1TP]+B"":#"0H8&82414:DM%;352@:\N/SQ-3D]&5U
MA96EM<75Y?5F=H:6IK;&UN;V-T=79W>'EZ>WQ]?G]SA(6&AXB)BHN,C8Z/@I
M.4E9:7F)F:FYR=GI^2HZ2EIJ>HJ:JKK*VNKZ$0`"`@$"`P4%!`4&!`@#`VT!
M``(1`P0A$C%!!5$382(&<8&1,J&Q\!3!T>$C0A528G+Q,R0T0X(6DE,EHF.R
MP@=STC7B1(,75),("0H8&28V11HG9'15-_*CL\,H*=/C\X24I+3$U.3T976%
ME:6UQ=7E]4969G:&EJ:VQM;F]D=79W>'EZ>WQ]?G]SA(6&AXB)BHN,C8Z/@Y
M25EI>8F9J;G)V>GY*CI*6FIZBIJJNLK:ZOK_V@`,`P$``A$#$0`_`/OIBKL5
M=BKL5=BKL5=BKL5:VIMD.,P'J9<36U/'!QF8]#'Q$LO]0L=.M'OK^\BLK2'>
M:ZF;A&GWY7GG/!'BE/;W,\0R9S6,/"M=_/&*8W=A^7^D3>:+NUC]2;5'/HZ;
M`*;2S3'HGC]C.9U'M3&!H8^/X\/^]=KC[.A'_&95]OW(#RW_`,Y%:2]W'H?Y
MC:7<?E]YA'0WJ<[&6@_O8I@/[LGO2G^7FM[,]O=)EGP:V/@Y+V%RR7\8QH-F
M;L;)+^Y-_CS+Z%BO;._LTO+*YCN[26CQ743<T>OA3.[!&>`E_"=QYNCRXQA-
M9_Q\DSW^>72B:V-+P!V_;(CBCSW^Q/#%O"AV*NQ5V*NQ5V*NQ5V*O__0^^F*
MNQ5V*NQ5V*NQ5V*NQ5)M6US2]#LGOM6U*WTVTC_W?.PC'XYKM3VC#00XM1+[
M/^)!;L>,DU3Q"_\`S@UCS"\MC^6GER763'M+YDOE^KV,)I_>5(J<Y[/V_P#G
M_3H^?X_G`.SQ]G@[R-?C[7Y]_F[_`,Y8?ESY?\P1>4K.]U;_`)RD_.2[E^KZ
M;^67DMY9=)BNAMZ<UY!$2:T^Q;15\<V_97L'JLOK[3GMSY#_`'DA37F[;Q`5
MI8\/X_I!YEY@_)K\]OSGM8[K_G+/S\GY8>1*?6=(_P"<7ORX>.VE$?6$ZK+^
M_AC_`.,DOUB3_C'FTUOM1H/9>/#IH<9`J[D/O$F.F[.S:\WD/7R_04K\O^1?
M^<@?RETLK^0?F"+_`)R:_*"PI+J7_./OGA?^=@TJ*F_Z*E!I)0#^\L91N?\`
M><G*--[2]A^VT##41\&?*KR3^T"%?/9.?3ZWL\W'E_F_M^UZO^2/_.27Y?>;
MM9DT3\M?.VI_D7^9\5P8]7_(S\PG].WENJ&L=I=3TCD]HW].7VSF.U/^!SG[
M(D<FBEPQ[Z!^R<Y.3INVM%*AK8WY[[?Z4/O/2O\`G(&;1+J+0_S=\K77DG4'
M/IQ:Y&#+ID]1N0=Z?(<\P]%[6?ESP]I>@_/_`*9Q7+V0>'B@01^/-]$:9K&F
M:U81ZEI.HV^IV4W]U=6SB2,_2*C.PTW:6/6X^+1GB'?R_P!T`Z3+I91E2=YL
M6+L5=BKL5=BKL5=BKL5?_]'[Z8>2NR)R*UDKME;>`RX5MV(G;%V)G2L5U_S/
MH/E>R^N:YJEOI\!!]'U)*22'PCBZR?1FLU.N_)PO4&_L_P!S;9BQ'42>1R?F
M-YV\Z,]I^7'EE[73_L?XMUE?3A/_`!BAZG-#E[;U.KVT(KY?[\.WQ:'#AWR2
M^&[XI_.7_G)?\@/R?UI=%\P:[JG_`#DS^=LDGU:S_+?RO_I$5O==?2EE@_=1
M?\8_WDG_`!5FW[-]B)99B><_CX2<7/VL3'A`H?CR8+-^3O\`SEQ_SE5IPU3_
M`)R.\Y0_\XL?\X^BK1?D_P"6S]7U.[M14^E=^%1_OZN__'MG79]9HNQX#@(-
M#F+_`./?8ZLRG-ZQY0TK\I_R,T:3RG_SCUY(M?*$$T?IZQYZG3ZQK>I?*ZF_
M>_1V_P!]QYY5V_[=Y^U!P\?V#_B0]7V?V-CQFY'X;_K8[<N\R7$\\CR22^K)
M--)_>R9YWX.24K,_L>EK#`5?WO+[.[NM-N;>]TZ[FLM0M9/4M+N!_3ECESB,
M>LEIIB0Z.QRQP9(U?WLU\V:=^1__`#D58P>7O^<D/)4$VN11_5M'_-_1T^HZ
MO:=!_I4L((D^7[R+_BO/9_9/_@JY-!$1/X_V!>*[3["A,\4/E^"QF7R-_P`Y
MC_\`.*>DK)Y*U&U_YS4_YQL:/U1Y/U0&YUNRLJ;"U/[^4T'^^O5C_P"*H\]D
MF>R_:/$1E%&7G+K[N%Y/#FEI3?X_2S[\DOSF_(W\Y;Y5_([\R;S\EOS6/_'4
M_)_S23'ZDU:2QP+-RBN.Y_=F0C_?<>>>:_V!U?9V0S[-D0/<#_NY%WV'MHYH
M\,P#^/<^NX/SF\V^2Y8],_.+R=<:?$:1P><-&7ZS8/\`\9:;C]?_`!7FKC[3
MZCLTB/;$.$GK8/V8@5R]FXLPO&;\MWT#H7F?0?-.G1:CY>U:VUBPDI^^M9!*
M-Q^W3['TYVN@[3TW:./BT_K'QC_N@'39H_ECR9/FTY,79'AM78.:V['DMNPC
M(KJY+B5__]+[Z8(FU>%_F%^?_P"7_P"7OF+3_(\PU;SC^8VKP?6M-_+?RI9R
M:MK<EM6GUF6&']U;6_\`Q;<RQQ^^9$=/Q"^B6+:Q_P`Y#Z_Y4M/TKYS_`.<>
M/S,T+0E3G=:W86^E:]]5C'62[M-'U*YN_P#D5%)ED,'%R(_'S8<3,/R@_P"<
M@ORB_/B'5[K\I_.,'G&T\O):G6+JWAFBCAFO?4]**03Q0_O/W1VS'U&(QYKQ
M)U^<WYI>7_R5_+3S=^:'F.UNK[2/*EH+B>QL4$ES<.91%%%$":<S)(!AP8^(
MTR3/\L?/V@?FG^7_`)/_`#'\K,9-!\ZZ7;:KIS.`)4CN(@WIRT_W9$?W9]\&
M;'1I+&_SF_,(?E/Y`\Q?F/=>2KWSC8^4[.74M>L],:U%['8VT9EFFB%VT(D]
M(;TK7*\6GC/:7J^Q,L_A\GE_D[_G(_7?.WY9>7_S9\O_`)&>;;_R+YALAJFG
M1Z=<:/=:F;&A_>C3Q>B60GM''5_;,F.EPPVNC\6J0R9SM^AZ1^5OGO\`*+\T
M/*-K^9'Y;76DWFA2+*)M5BM8[.XL98?]ZX;J.:-9;>6+_=B24^[,?5PUG'5G
M["RD8CFD>F_G:GG?2G\Q_EW^6_F/\R?)T#N+/S59_HRSM=2]&@,NDC4[RVEN
MHZ]):"*3_=4DF63T6*4:SG?X_H1CU,0\]U+_`)RD\J)Y`T'\P]$_*;SEYGCU
MCSW)Y`E\D6VFQ1^9+>_MS,9O]Q\TH_N9+5J@RI_OS&.@Q0-<73N-?CX,OS>3
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MX0N0X1[V@98YMDJU3S[/HS/K?G#_`)QW\QV-E#)ZTNMZ=;Z/KUS#_P`6RVNF
MWD]X3_QBBDR4,<Y2K'.OL1MB>F>3/.GDO\RO+UGYF\G>8+'S=Y>U$$PZE9R<
MXQ("#)'*`?W<D?>-P'0[$=LQ,L<^`\,(;=]C].[=B&7%N3]SPW\[?^<D_+W_
M`#CCJOEB;S[Y"UNP_+[S3J5MI5Q^:NFI:W&F:;<W&X_2$0F^M11^_I?+?,O2
MZ&$]X;SZCE^FFO-F$_JW?4-I>6FI6EO>V5S%>65[''/:W4+^I')'-_=212#;
M<;YC9-DO/OS:\_77Y7^1M>\^IY3U/SI9^6+.74=5TK2);>.]^JVT9FFDB$\L
M`DH/V*[YD8(<>UI><_FQ^?FI_E#^5#?F[YG_`"H\PW&AZ;:QWOFS0]/NK"XU
M#2HY9A$OJ1^L(9:<_P![Z<IX#)X,(D:O=JXF'_EG_P`Y2>:_S:\D:%^8OD#_
M`)QQ\Z:UY/\`,<<TNDZC)JGENU,GH32P2_NIM3$NTL3CIAS8!':T<3*?*7_.
M0VKZQ^:VD_E-YM_(_P`[?EIJ^N:9?:IHWF'6?T7=:1<Q6'I>M%%=Z;>W(]7]
MZGP9&6G`%C?\>]N?3U<HI#__T_JS_P`Y:_GW:_\`.-OY'>;_`,RC'!<:[%#'
MIWDO3Y-H[C6+ZL5K6M!Z<7Q2R_\`%:'+=%A\0L9L8_YP\_)>X_++\L+/S3YN
MGFU_\Z/S9CA\U?F]YPO6$E]=ZA>1^K%:F4C^[LXY/2BC'[L?'3KEVMR<6W0;
M+!]A',.,V3P_\N/R2\L?EAY__-[SAY6M;;3+/\V;S3-6UC2[:/TXX]3LHIH;
MN44%#Z_J))_QDYY>9V$A1\_V-CY[_,3R=^7>HV\=]H.E:7J?FKSA:2)6*2.>
M*71].@EZ?WWUFYD_YX9+'(P-CFTSW?)/_/N_5;[R7IWYT_\`.+'F*\:76O\`
MG';SG=VV@>HX]27R[JTLL]G+],GJ2?[-,RNT(B8$AU7'L^L/^<HO_6;/^<@/
M_-=^9_\`NES9BZ'?4CWLYL$_YP3-/^</_P#G'X^'E2U_Y.29;VCB_P`)/E7W
M!<3\[_RP\J>=O.WDS_GZ+<_D\MS)Y3_,'7]4L_RT6P!,6I7T`O/TM^CR/M^O
M'(D8,?7DF;')&$>"^?7Y?K^YJ$7WQ_SA5^?OY8_G'^2_D'0_*&J6MAYJ\B>6
M].T+S9Y#9Q#?:;<Z?;16DP^J['TJQ'TI.E/IS4ZK'*R6T/JV+RWH-O=F\M],
MMXK@ZC)JIF1=S?30_5);FO\`OPQ?N_EE)G45QOE__G/W_P!8Y_/W_P`!L_\`
M45%F1V6>++'X_<N1ZE_SC;_ZSK^0_P#X`'ES_NEPY#5G_"#[TXWB?_.</YTW
M?_.-?_../G3S;Y-BCL/.'FJ_CT7RM=I_NO5-5,GJW5/YXHHI)?\`C)E^ATHS
M:C?\;(R/7?\`G&S\IM+_`"8_*#RIY/L(WFU:2TCU3SKK4Y]6YU+7[Z,3:C?W
M,I_>2R32]R:\.`RC6:CBFR>_YB9AQ15^7GYB:Y_T+%_SG1^5%[Y?!L_R]_YR
MZ$^E>?\`RXAXVW^)K*6*&TU>*(#]W/-]:ABE-/WGQUJ<W>(?F,!/4<FC-]3[
M`_YR1\H^7O/_`.7^E^1_-6GIJOEGS9YL\NZ7K=@YIZUO-J$7?MOFMT4OR^0D
M<VS-]+XP_(CSKYI_YPY_-73O^<2OSJU>;5?RL\SRR/\`\XR_FM>FD?HM)0Z#
M>2$_NY(2XCB\#_Q5)$(]IK(#M*'YH?6.?PV\ARKIR8Q%;/O_`/.RO_*G?S6'
M;_"&L_\`4)-FIQY)``]6X&GEG_.8W_K(OY^?^`'JG_4*<R^S-]4/C]Q:LG)@
M?_/M[_UBW\D?^8+4_P#NJW>'M6/^$_#]",3[.NM.L+V]TN^N8$FO-&DDET^6
MO]WZT9AE_P"2<F:_Q&U-/HQ\17__U.S?\_:+J34)_P#G%/R9.]=#\Q^>Y)=8
MB_W6X@^J0[_\\[I\WG8F/BA(^[]+#(_8M5X*J)LD>:(SXITF"_Z</ALG8*5\
MF>4_*_G?\P/,7YA_FEY>_-?4O)FF^8=8DT'0]-L-.TJ]CDTWRW++I\4OJWMI
M<2CU;KZS+_L\R<@X2`6F'J?)_F[2->_YQJ_YSF_)?\SM?\Y7GFS0/^<E-/NO
MRZ\Z:W=VEC9\-4M_2_0_JQV<,$7:&,'K\+YL(@9<1`'T_P!OV[LL@X7W/_SE
M%_ZS7^?_`/YKOS-_W2YLUV@VU(][+(^;/^<//R>\B><?^<1?R1'F:UUC5[/6
M/*L$FHZ')KNLC3+BLLFTNGQ7@@,?_%?I^GF3K]01J?QW+C?=6DZ7Y<\H:-I>
MB:+I^G>5O+]B([/2-)LXH[.VMQ_NJ*&&(",=.@S7<4H_4V&+XS_/_P#YP3_+
MG\VM8N/S)\@W=[^27YZ02&]TC\RO*[O9M-?4!$NH10T]7_C(.$GOF?I^T1':
M7J#7)&?\X3?G+^9GYF^5OS%\B?G1!`_YI?D9YLF\H>9];M%*0ZFL$8,%UMQ'
MJ&CU['X).^.NTP@`1R(7&R/_`)S\_P#6.?S^_P#`</\`U%19C=DFLH^/W+D>
MI?\`.-G_`*SO^0__`)K_`,N_]TN'(ZTUJ?BL'R__`,_./RPU_P#,K_G%G6[G
MRU:O?ZO^6VLV/F\:?#\<D]K8QS0W?O\`N8KEY?\`89LNQ\XCJ:*,C[*_*7SU
MI'YG_EEY&\_Z#<1W>F>;-&LM1ADC-0/7C_>1=!_=2<T_V.:O58JF?>V/1>^,
M_I0_++_G*/19_P`Y?^<Y?^<0_P`M-`K=/^4)N_S%_,"ZC%?J%B+JTEM!+WC]
M::Q2/_9IFVT<O!P2/>X^7ZGWG^;NVE^2/;SYY7_[J$6:O#ZY'R!;<WTL=_YR
M!_(;R5_SD7^6>M?ESYUM6C2[I<Z%K]O'_I>E:G#40WUJ33>+P_W8A,9ZY/2Z
MPZ2?$/I9D/AW\M_SY\\:?Y*_.G_G$S_G(R9K7\\/R[\CZP/*_F9B?2\X:##I
M\QAO[:4DF6X$?][W?_C(DN;++HN&0U0^@G]G??/RV:C)]>_\YC?^LB?GW_X`
M&J?]0IS$[*_QL?'[BG)R?+G_`#@7^9/G30_^<2?R@TO2OR)\Y>;K&ULM0]'S
M%IMYY<CM+NNJ7?\`=?7=8MIMO[O]Y$.F97:4`=2=_P`4C$^FOR6_.;\POS)_
M-;\W_*WG'\K=8_*K3_(VD>7)-"T/79[2XNK[]*2ZJ)KX364L\/IUM4C_`'<T
MGV<P-1IQ``@VW/JO,"D/_]7U?_S]8_*_6?-WY`Z+^8_EJ)[C7/R4U^+S%*J5
MYBPF_<W4@%/]TR>C*?\`BM'S9]BY1*XGK^ACDY/O7\G/S&T;\WORO\C?F9H4
ML=QI_G+2+740$W].5H_W\/3[<,H:,_ZN86KT_AY#Y?@+!Z?3,02E+HSNGF'Y
MM:CYUTSR3K'_`"KZWMI/.=_!+9Z!=WT5U+;VES-%)Z5S-%9PW$T@BIN`,R\$
M(?Q%%6PO\I-4?R;^6GD?RAKVC:JNK^5]&LM*U*33M)U6XMKB:"(0RW,4LUG!
M)2:2LG2N&>,`<VK'ED7@G_.:7Y>^8?\`G([\N-&\D^0[:;R_Y@T'S%8>9M'\
MWZQI6LQ_4+JQ]7^ZCATV<F3][E_9>KABF3:Y)29M^95W^:7YA?\`.//FC\NY
M]$L[?\R_.OERZ\N:YJHL->&CQ"^M/0O+Z'_<;ZW^[']*/_DIC@CCQZCCZ)X;
M5O\`G%ZP\R?D]^2WDK\J_/>GS7FI>1+`:79ZUH6EZQ);7=J)9?1D,<UE`8Y/
M'!J1'+GXQ^-EX>%EWYX6<GYK?E]?>4/+^O\`FC\N];FU31M3TSSA:>7+^YN;
M&72M0M=1$L4)A`D/^C4RK32C';FB<I!*[/SY^?5II[:7?:-Y=UO4XXQ'!YO&
ME>9[&%R/]W2Z2-,G._\`ON.[_P">F69(8XV05ADEU5?R4\L>6_R?T/S';<O,
MGFCS9YZ\P7WFO\P?.%QY=U"WEU/5[]AZTD4/H?NHH1QCBB_W7&OTY#52CDWZ
M(EDD),9_YRLTSS+^<_Y+><ORK\A:=+97WGFS&GZAK&NZ5K445I;>K'+-Z<4&
MG3^K)2/88=-.%[GDSU$Y<.P9?^1.H:[Y%_*?R)Y&\]Z3=2ZYY)T.PT$:AH6E
M:Q<VMU%80Q013#U[*"6.OI_W9R&KC`29\WL#^>](=7232O,,D<G^ZOT#J?\`
MU0R$\8,4U3YB\O>1;G\G]2UBX_(2^U'R]Y4UZ]EU#4?R?\P^7-8N=#@O9R99
M9M)FM(1-IOK`U,7[R+PB3+XG'(4>?>'$!E%FU_YX_.O6(/J-AI.C>1I)5*3>
M8/T7YC\P21U_W9%:?HVPBY^TLN/Y;%C-W?X][<)S+?Y2^4/(OY3?XAU.RM?-
MWF;SQYVO!J/Y@_F'K&BZA-JVM76_I>K+!9+%''"*1PV\?IQ11]O$YA8K9ECB
M@OSOU/SUYKM/(]K^6FE".30O-6C^8-?N/,.FZ[;K/::7="8VD/HZ9/\`O)J?
MWG^Z\&@C`$V5F'M]MY^T]H+=KO1?,%O<%*S0IHFJ2QQOW_>_4\QCBC#9L(?(
MW_.7?Y'^3_\`G);RC8-9VVN>6OS0\F/];\@><TT+5(Y(FY?O+&ZFA@!^KS]_
M]]_W@[UV.AR#!*SR+60]'_YRXOX=2_YQ"_/JZA@NK:,^2-43TKJVDMI!^Y/^
MZ9J'*>R)WJQ\?N+#40H,._Y]O_\`K%OY)?\`,%J?_=5N\M[7_P`:^'Z%P/M1
M+&SCO9+]+9/KTMO'!/<\1ZCQ0&0Q1_1ZCYK.&FU'9*E?_];[P:C8V&JV5UIN
MHVT5]87\$EM?6,R^I%-%,#%+')&1NA'7(#+^6D*]_P".:)A^>_E7\AOSS_YQ
M,\PZV_\`SC=;:=^:/Y%>9[R34+K\B==U']$ZCH5W<#][)HFK3>O%Z6V\<WWU
M_>9M,^H&<`G8HQA[?%^:O_.1VO\`HZ=H/_.,%UY2OYB8YO,/G;S+HT>F68H:
M2^EHT^H7=R?\B.*,?\691'@(N_Q^.]CEE3/X/*?G31?*6LO=^<=1\V^>]9NH
MKR[OX?\`0;:.8^G#]6T^S]7TK6VBB!'`F20_WDDDDN^:;M*$^<7(TV_-[)'&
M8XEC21Y?3']Y(WJ2?><RY0D8,<<XEY9IMMYY3S):37TTXT(:OJ\C(S=+7T_]
M#]0^J?@!Z"G7-'BQY!D<N1AP^;+O.XUB7RQJD?E^26/6Q''^CC"U)*^I'7K[
M5S9ZXRAI^(<Q7WN-AC:>:4URNGVBW1;ZQZ?[[GCH)2G@XCSW7-&N3S_18_.,
M/G+5;C4);J3RU<27B:?!(T91*?53#)2H/#^__P`_3S6SGDCG`\W)R&'"*9GK
MJZC+IEY;:9))%?7E;:&[3_CW];;UO^>77-OK^(8K#CB<;"CY6EUA]`TH:["\
M&LQP&/4%Y@\Y828O4V[2TYC*-!&63%<DZB48RVY)!:V'F1_.^K7]SJL]MY=M
M6A_1]A\,D5URM:25KO'Z4HY^^8VEC/QB&R4HF`V37SNNNRZ)P\O221:F+ZPH
M8>OH_6HO7Z]O2YY9KQ+B%-6``\V1:>9C8VOU@MZWH1^KS^WZE-Z_3F9AA(P%
MHS"N3S?18O-Z>9+-=1-Y)I<<^N&[D>2,V[QR3Q'3]AOM%SV['-%##FCF`\_)
MRLY@!LRGSG%JMSY7UU=!DGCUD6<WZ*-N_IR?6?2/I;GWS9=K^)##<2TX91O=
MD5M']7MT3G+)P2M9F]27Z<S("9@TP"0>74U5+KS.-3]?T)-7D;2!,W_'KZ,5
M/2IT'J\\ITPD)%9A`:O%K<OF6R%;@^7);%XZV<GIR0WIF`]24U'P>GL/]EF+
MK)3&8!MIE.H&62RO8X6DCF]"3TY(?[WG3_==??-CJ8R&*QS:R'Q[_P`Y-V/Y
MK^8O^<;?/7Y;>5OR\U+SYY\\\:7=:#:S6ES:6UM'%<2^A];NI;Z['I_NCZGI
M@R>&3[#S`:JY;`#]"=3$='E7_.'VH?GI^1OY"^3?RE_,'_G&7SC=:SY/>_MH
M=0T+4?+=S;W%K-=2WD,A];6;?TW'K>G3_)S<=H&.347$[?L<;%L7O%AYZ_/3
MSQ^9WD;0X_R/US\M/RQTZ2ZU3SMYPU_4M&>XNI(;63ZI80V>FWET>$MS(DDD
MG^13,(Q`'-N?5]<J13__U_OIBKL5=BKL5=BKL5=BKL5=BKL5=BKL5=BKL5=B
4KL5=BKL5=BKL5=BKL5=BKL5?_]D_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
